FFA
GMAB icon

Frazier Financial Advisors’s Genmab GMAB Stock Holding History

Frazier Financial Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-465
Closed -$11.3K – 744
2024
Q3 		$11.3K Hold
465
– – 0.01% 342
2024
Q2 		$11.7K Hold
465
– – 0.01% 409
2024
Q1 		$13.9K Buy
465
+131
+39% +$3.85K 0.01% 336
2023
Q4 		$10.6K Buy
+334
New +$10.5K 0.01% 337

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Frazier Financial Advisors's GMAB Position: Q4 2024 in Review

Frazier Financial Advisors sold out of Genmab (GMAB) in Q4 2024, closing a stake of 465 shares — an estimated $11.3K sold.

Frazier Financial Advisors first reported a position in GMAB in Q4 2023 and held it in 4 quarters. The position peaked at $13.9K in Q1 2024. 228 funds tracked by Wall St. Rank hold GMAB as of Q4 2024.

  • Frazier Financial Advisors reported no remaining Genmab position as of Q4 2024 after selling out during the quarter.
  • Frazier Financial Advisors sold 465 Genmab shares in Q4 2024, an estimated $11.3K.
  • Frazier Financial Advisors first reported a position in Genmab in Q4 2023 and held it in 4 quarters.
  • Frazier Financial Advisors's Genmab position peaked at $13.9K in Q1 2024.
  • 228 funds tracked by Wall St. Rank held Genmab as of Q4 2024.

Based on Frazier Financial Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.